Azione 300832 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Shenzhen New Industries Biomedical Engineering Co., Ltd.

Azioni

300832

CNE100003T39

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 30/04/2024 		Variaz. 5gg Var. 1 gen.
70,7 CNY -2,19% Grafico intraday di Shenzhen New Industries Biomedical Engineering Co., Ltd. +0,78% -9,59%
26/04 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : Nomura ancora positivo ZM
25/04 Shenzhen New Industries Biomedical Engineering Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices
Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25%
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen New Industries' Profit Jumps 32% in H1
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 08 June 2023
Shenzhen New Industries Biomedical Engineering's Shareholders Plan To Unload Company Stakes
Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-MAY-2023.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Proposal for 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenzhen Yinghe Brain Science Co., Ltd announced that it has received $14.800000 million in funding from Eli Lilly Investment Consulting Shanghai Co., Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Beijing Enlight Media Co., Ltd., Xi'an Xijiao 1896 Capital Management Co., Ltd., Shenzhen Qianhai BangQin Investment Co., Ltd. and other investors.
ANALYSEN DES TAGES von Dow Jones Newswires (18.01.2023)
Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Hormone Kit
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend for 2021, Payable on 23 June 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 2021
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300832
  4. Notizie Shenzhen New Industries Biomedical Engineering Co., Ltd.
  5. Altre lingue